Financials
- Market Capitalization 387.95 M
- Employee 214
- Founded 2000
- CEO N/A
- Website www.eyepoint.bio
- Headquarter Delaware, United States
- FIGI BBG000F90JX5
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.81
売上高対価格比率
0.4
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3068 | GALT Galectin Therapeutics Inc. - Common Stock | 3.95 USD | -1.74% | +1.02% | +33.00% | -7.71% | 398.36 M USD | ||
| 3072 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.04 USD | 0.00% | -0.25% | +0.75% | +36.03% | 400.55 M USD | ||
| 3111 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.30 USD | -2.21% | -5.67% | +4.72% | +52.87% | 387.37 M USD | ||
| 3117 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.76 USD | -2.06% | -4.23% | +14.70% | -0.21% | 390.54 M USD |